BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18760875)

  • 1. Regulation of p53R2 and its role as potential target for cancer therapy.
    Wang X; Zhenchuk A; Wiman KG; Albertioni F
    Cancer Lett; 2009 Apr; 276(1):1-7. PubMed ID: 18760875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastasis-suppressing potential of ribonucleotide reductase small subunit p53R2 in human cancer cells.
    Liu X; Zhou B; Xue L; Shih J; Tye K; Lin W; Qi C; Chu P; Un F; Wen W; Yen Y
    Clin Cancer Res; 2006 Nov; 12(21):6337-44. PubMed ID: 17085643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
    Piao C; Jin M; Kim HB; Lee SM; Amatya PN; Hyun JW; Chang IY; You HJ
    Oncogene; 2009 May; 28(21):2173-84. PubMed ID: 19398949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structurally dependent redox property of ribonucleotide reductase subunit p53R2.
    Xue L; Zhou B; Liu X; Wang T; Shih J; Qi C; Heung Y; Yen Y
    Cancer Res; 2006 Feb; 66(4):1900-5. PubMed ID: 16488986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer.
    Liu X; Zhou B; Xue L; Yen F; Chu P; Un F; Yen Y
    Clin Colorectal Cancer; 2007 Jan; 6(5):374-81. PubMed ID: 17311703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox property of ribonucleotide reductase small subunit M2 and p53R2.
    Liu X; Xue L; Yen Y
    Methods Mol Biol; 2008; 477():195-206. PubMed ID: 19082948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53R2 is a prognostic factor of melanoma and regulates proliferation and chemosensitivity of melanoma cells.
    Matsushita S; Ikeda R; Fukushige T; Tajitsu Y; Gunshin K; Okumura H; Ushiyama M; Akiyama S; Kawai K; Takeda Y; Yamada K; Kanekura T
    J Dermatol Sci; 2012 Oct; 68(1):19-24. PubMed ID: 22902076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of high-risk human papillomavirus oncoproteins on p53R2 gene expression after DNA damage.
    Lembo D; Donalisio M; Cornaglia M; Azzimonti B; Demurtas A; Landolfo S
    Virus Res; 2006 Dec; 122(1-2):189-93. PubMed ID: 16872707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribonucleotide reductase small subunit p53R2 facilitates p21 induction of G1 arrest under UV irradiation.
    Xue L; Zhou B; Liu X; Heung Y; Chau J; Chu E; Li S; Jiang C; Un F; Yen Y
    Cancer Res; 2007 Jan; 67(1):16-21. PubMed ID: 17210678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P53R2, p53 inducible ribonucleotide reductase gene, correlated with tumor progression of non-small cell lung cancer.
    Uramoto H; Sugio K; Oyama T; Hanagiri T; Yasumoto K
    Anticancer Res; 2006; 26(2A):983-8. PubMed ID: 16619496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in radiosensitivity using small interfering RNA targeting p53R2 in esophageal squamous cell carcinoma.
    Yokomakura N; Natsugoe S; Okumura H; Ikeda R; Uchikado Y; Mataki Y; Takatori H; Matsumoto M; Owaki T; Ishigami S; Aikou T
    Oncol Rep; 2007 Sep; 18(3):561-7. PubMed ID: 17671702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Akt and p53R2, partners that dictate the progression and invasiveness of cancer.
    Yousefi B; Samadi N; Ahmadi Y
    DNA Repair (Amst); 2014 Oct; 22():24-9. PubMed ID: 25086499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion.
    Bourdon A; Minai L; Serre V; Jais JP; Sarzi E; Aubert S; Chrétien D; de Lonlay P; Paquis-Flucklinger V; Arakawa H; Nakamura Y; Munnich A; Rötig A
    Nat Genet; 2007 Jun; 39(6):776-80. PubMed ID: 17486094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of p53R2 in cancer progression based on the new function of mutant p53 and cytoplasmic p21.
    Yousefi B; Rahmati M; Ahmadi Y
    Life Sci; 2014 Mar; 99(1-2):14-7. PubMed ID: 24486301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infrequent alteration in the p53R2 gene in human transitional cell carcinoma of the urinary tract.
    Hayashi H; Furihata M; Kuwahara M; Kagawa S; Shuin T; Ohtsuki Y
    Pathobiology; 2004; 71(2):103-6. PubMed ID: 14707445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53R2 inhibits the proliferation of human cancer cells in association with cell-cycle arrest.
    Zhang K; Wu J; Wu X; Wang X; Wang Y; Zhou N; Kuo ML; Liu X; Zhou B; Chang L; Ann D; Yen Y
    Mol Cancer Ther; 2011 Feb; 10(2):269-78. PubMed ID: 21216934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribonucleotide reductase subunit p53R2 regulates mitochondria homeostasis and function in KB and PC-3 cancer cells.
    Wang X; Liu X; Xue L; Zhang K; Kuo ML; Hu S; Zhou B; Ann D; Zhang S; Yen Y
    Biochem Biophys Res Commun; 2011 Jun; 410(1):102-7. PubMed ID: 21640705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genotoxicity test system based on p53R2 gene expression in human cells: assessment of its reactivity to various classes of genotoxic chemicals.
    Ohno K; Ishihata K; Tanaka-Azuma Y; Yamada T
    Mutat Res; 2008 Oct; 656(1-2):27-35. PubMed ID: 18674635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of the p53-p53r2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis.
    Yoshida T; Haga S; Numata Y; Yamashita K; Mikami T; Ogawa T; Ohkusa T; Okayasu I
    Int J Cancer; 2006 Mar; 118(6):1395-403. PubMed ID: 16206288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic property analysis of p53R2 subunit of human ribonucleotide reductase.
    Yen Y; Chu B; Yen C; Shih J; Zhou B
    Adv Enzyme Regul; 2006; 46():235-47. PubMed ID: 16846634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.